1<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1"/><link rel="preload" as="image" href="/images/short-cote.png"/><link rel="preload" as="image" imageSrcSet="/_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=640&q=75 640w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=750&q=75 750w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=828&q=75 828w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=1080&q=75 1080w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=1200&q=75 1200w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=1920&q=75 1920w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=2048&q=75 2048w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=3840&q=75 3840w" imageSizes="100vw"/><link rel="preload" as="image" imageSrcSet="/_next/image?url=%2Flogo-kat.png&w=256&q=75 1x, /_next/image?url=%2Flogo-kat.png&w=384&q=75 2x"/><link rel="stylesheet" href="/_next/static/css/606d1024b658d130.css" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/d440bf5f48d6ae05.css" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/e7eddfe4828c1690.css" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" href="/_next/static/chunks/webpack-0bfbc16c93757d76.js"/>
1<script src="/_next/static/chunks/4bd1b696-502fa764d97d2086.js" async=""></script>
1<script src="/_next/static/chunks/517-12d40c8ae64ee55e.js" async=""></script>
1<script src="/_next/static/chunks/main-app-a849309caff0f7ba.js" async=""></script>
1<script src="/_next/static/chunks/540-97d91d4b11344914.js" async=""></script>
1<script src="/_next/static/chunks/877-ee309be1ac8e8911.js" async=""></script>
1<script src="/_next/static/chunks/173-f571c60da90961a5.js" async=""></script>
1<script src="/_next/static/chunks/87-7e5cd4c266b609b6.js" async=""></script>
1<script src="/_next/static/chunks/app/%5Blocale%5D/page-d1e19f60fdc30825.js" async=""></script>
1<script src="/_next/static/chunks/app/%5Blocale%5D/layout-c8a0e19d9e635596.js" async=""></script>
1<title>KAT innovation</title><meta name="description" content="Welcome to · KAT Innovation · A Future Free From Osteoporotic Fractures · Solution: Bone Growth Stimulation · Our Product: OSTAAT â¢. One STimulation At A Time."/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><link rel="icon" href="/favicon.ico"/>
1<script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule=""></script>
1</head><body><div class="top-0 left-0 w-full fixed z-30 backdrop-blur-sm h-16 bg-white shadow-md"><div class="relative px-10 py-4 mx-auto h-full transition-all"><div class="flex justify-between items-center h-full"><a class="relative group" href="/en"><img alt="logo" loading="lazy" width="80" height="80" decoding="async" data-nimg="1" style="color:transparent" srcSet="/_next/image?url=%2Flogo-kat.png&w=96&q=75 1x, /_next/image?url=%2Flogo-kat.png&w=256&q=75 2x" src="/_next/image?url=%2Flogo-kat.png&w=256&q=75"/><span class="absolute left-1/2 -translate-x-0 top-full mt-2 px-3 py-1 text-sm bg-grey text-white rounded-md opacity-0 group-hover:opacity-100 transition-opacity">Home<!-- --> </span></a><nav class="hidden lg:flex justify-center items-center"><ul class="flex gap-x-7 font-medium"><li><a href="/en/about-us"><p class="relative group">About us<span class="block h-[2px] transition-all duration-500 max-w-0 group-hover:max-w-full bg-current"></span></p></a></li><li><a href="/en/problem"><p class="relative group">Problem<span class="block h-[2px] transition-all duration-500 max-w-0 group-hover:max-w-full bg-current"></span></p></a></li><li><a href="/en/solution"><p class="relative group">Solution<span class="block h-[2px] transition-all duration-500 max-w-0 group-hover:max-w-full bg-current"></span></p></a></li><li><a href="/en/our-product"><p class="relative group">Our Product<span class="block h-[2px] transition-all duration-500 max-w-0 group-hover:max-w-full bg-current"></span></p></a></li><li><a target="_blank" rel="noopener noreferrer" href="https://www.fraxplus.org/calculation-tool"><p class="relative group">FRAX<span class="block h-[2px] transition-all duration-500 max-w-0 group-hover:max-w-full bg-current"></span></p></a></li><li><a href="/en/achievements"><p class="relative group">Achievements<span class="block h-[2px] transition-all duration-500 max-w-0 group-hover:max-w-full bg-current"></span></p></a></li><li><a href="/en/news"><p class="relative group">News<span class="block h-[2px] transition-all duration-500 max-w-0 group-hover:max-w-full bg-current"></span></p></a></li><li><a href="/en/clinical-validation"><p class="relative group">Clinical Validations<span class="block h-[2px] transition-all duration-500 max-w-0 group-hover:max-w-full bg-current"></span></p></a></li></ul></nav><div class="lg:hidden"><div><div class="flex lg:hidden cursor-pointer"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="icon icon-tabler icons-tabler-menu-2"><path stroke="none" d="M0 0h24v24H0z" fill="none"></path><path d="M4 6l16 0"></path><path d="M4 12l16 0"></path><path d="M4 18l16 0"></path></svg></div><figure class="lg:hidden absolute rounded-md right-10 origin-top top-16 scale-y-50 opacity-0 hidden w-auto bg-white py-4 px-8 transition-all z-30"><nav class="w-full h-full flex flex-col space-y-2 tracking-wide"><a href="/en/about-us"><p class="relative group mb-2">About us<span class="block max-w-0 group-hover:max-w-full transition-all duration-500 h-[2px] bg-current"></span></p></a><a href="/en/problem"><p class="relative group mb-2">Problem<span class="block max-w-0 group-hover:max-w-full transition-all duration-500 h-[2px] bg-current"></span></p></a><a href="/en/solution"><p class="relative group mb-2">Solution<span class="block max-w-0 group-hover:max-w-full transition-all duration-500 h-[2px] bg-current"></span></p></a><a href="/en/our-product"><p class="relative group mb-2">Our Product<span class="block max-w-0 group-hover:max-w-full transition-all duration-500 h-[2px] bg-current"></span></p></a><a href="https://www.fraxplus.org/calculation-tool"><p class="relative group mb-2">FRAX<span class="block max-w-0 group-hover:max-w-full transition-all duration-500 h-[2px] bg-current"></span></p></a><a href="/en/achievements"><p class="relative group mb-2">Achievements<span class="block max-w-0 group-hover:max-w-full transition-all duration-500 h-[2px] bg-current"></span></p></a><a href="/en/news"><p class="relative group mb-2">News<span class="block max-w-0 group-hover:max-w-full transition-all duration-500 h-[2px] bg-current"></span></p></a><a href="/en/clinical-validation"><p class="relative group mb-2">Clinical Validations<span class="block max-w-0 group-hover:max-w-full transition-all duration-500 h-[2px] bg-current"></span></p></a><div><div class="bg-white"><div class="relative inline-block"><button type="button" class="px-2 py-2 text-black bg-white font-medium rounded-lg text-sm inline-flex items-center"><div class="flex justify-center items-center gap-2"><span class="fi fi-gb"></span><span>EN</span></div><svg class="w-2.5 h-2.5 ml-2.5" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 10 6"><path stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="m1 1 4 4 4-4"></path></svg></button></div></div></div></nav></figure></div></div><div class="hidden gap-2 lg:flex justify-center items-center"><div class="bg-white"><div class="relative inline-block"><button type="button" class="px-2 py-2 text-black bg-white font-medium rounded-lg text-sm inline-flex items-center"><div class="flex justify-center items-center gap-2"><span class="fi fi-gb"></span><span>EN</span></div><svg class="w-2.5 h-2.5 ml-2.5" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 10 6"><path stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="m1 1 4 4 4-4"></path></svg></button></div></div></div></div></div></div><div class="text-dark"><div class="mt-28 md:mt-40"><div class="mb-16 gap-8 md:gap-16 px-4 sm:px-8 md:px-12 lg:px-20 justify-center items-center grid lg:grid-cols-2"><div class="space-y-6"><h1 class="text-3xl md:text-4xl lg:text-5xl font-semibold leading-tight">Transforming Bone Health Through Precision Bioelectronicsâ¢</h1><p class="text-base md:text-lg leading-relaxed">KAT Innovation is developing a first-in-class Precision Bone Bioelectronics⢠Platform, a scalable ecosystem of wearable bioelectronic therapies for skeletal health, from Earth to Space Health.</p><a href="/en/our-product"><button class=" 2 justify-center 3 items-center 4 rounded-full 5 py-3 6 px-6 7 bg-gradient-custom 8 text-white 9 hover:opacity-90 10 transition-opacity 11 12 my-5 13 " type="button">Learn more</button></a></div><div class="w-full mx-auto lg:mx-0">
13<video class="flex justify-center items-center w-full h-auto object-cover rounded-3xl shadow-lg" autoPlay="" muted="" loop="" playsInline="" preload="auto"><source src="/videos/Landing_Site_v2 AN.mov" type="video/mp4"/>Your browser does not support the video tag.</video></div></div><div class="py-8"><div class="jsx-5893edf2a8852794 overflow-hidden whitespace-nowrap relative "><div style="animation:scroll 15s linear infinite" class="jsx-5893edf2a8852794 inline-block"><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F1.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F1.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F1.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F2.svg&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F2.svg&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F2.svg&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F3.webp&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F3.webp&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F3.webp&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F4.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F4.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F4.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F5.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F5.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F5.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F6.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F6.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F6.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2FmHUB.webp&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2FmHUB.webp&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2FmHUB.webp&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F8.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F8.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F8.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F1.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F1.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F1.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F2.svg&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F2.svg&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F2.svg&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F3.webp&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F3.webp&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F3.webp&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F4.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F4.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F4.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F5.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F5.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F5.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F6.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F6.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F6.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2FmHUB.webp&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2FmHUB.webp&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2FmHUB.webp&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F8.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F8.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F8.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F1.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F1.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F1.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F2.svg&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F2.svg&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F2.svg&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F3.webp&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F3.webp&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F3.webp&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F4.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F4.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F4.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F5.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F5.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F5.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F6.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F6.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F6.png&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2FmHUB.webp&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2FmHUB.webp&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2FmHUB.webp&w=256&q=75"/><img alt="Logo" loading="lazy" width="100" height="100" decoding="async" data-nimg="1" class="inline-block mx-4 md:mx-8 h-16 md:h-20 object-contain " style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fcollab%2F8.png&w=128&q=75 1x, /_next/image?url=%2Fimages%2Fcollab%2F8.png&w=256&q=75 2x" src="/_next/image?url=%2Fimages%2Fcollab%2F8.png&w=256&q=75"/></div></div></div></div><section class="py-12 md:py-20 px-4 sm:px-6 lg:px-8 bg-bgSection"><div class="max-w-7xl mx-auto"><div class="grid gap-8 md:gap-12 lg:grid-cols-[3fr_2fr] lg:items-center"><div class="space-y-6"><h2 class="text-2xl md:text-3xl lg:text-4xl font-semibold tracking-tight">About us</h2><p class="text-base sm:text-lg leading-relaxed text-gray-600">KAT Innovation develops and commercializes cutting-edge Precision Bone Bioelectronics⢠Platform technologies to address unmet needs in skeletal health, from Earth to Space Health. Founded on a genuine passion for innovation, KAT Innovation is dedicated to designing technologies that can change lives. Marcel Maroist, CEO and founder, is a dynamic and committed entrepreneur with extensive experience in health, fitness, and sports. His vision drives the company's mission: to establish the Precision Bone Bioelectronics⢠Platform as the global reference in bone health innovation.</p><div class="pt-2"><a href="/en/about-us"><button class=" 14 justify-center 15 items-center 16 rounded-full 17 py-3 18 px-6 19 bg-gradient-custom 20 text-white 21 hover:opacity-90 22 transition-opacity 23 24 25 " type="button">Learn more</button></a></div></div><div class="flex justify-center lg:justify-end"><div class="relative w-[65%] max-w-md aspect-square overflow-hidden rounded-lg shadow-xl"><img alt="Marcel Maroist, CEO of KAT Innovation" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent" sizes="100vw" srcSet="/_next/image?url=%2Fimages%2Fceo.jpg&w=640&q=75 640w, /_next/image?url=%2Fimages%2Fceo.jpg&w=750&q=75 750w, /_next/image?url=%2Fimages%2Fceo.jpg&w=828&q=75 828w, /_next/image?url=%2Fimages%2Fceo.jpg&w=1080&q=75 1080w, /_next/image?url=%2Fimages%2Fceo.jpg&w=1200&q=75 1200w, /_next/image?url=%2Fimages%2Fceo.jpg&w=1920&q=75 1920w, /_next/image?url=%2Fimages%2Fceo.jpg&w=2048&q=75 2048w, /_next/image?url=%2Fimages%2Fceo.jpg&w=3840&q=75 3840w" src="/_next/image?url=%2Fimages%2Fceo.jpg&w=3840&q=75"/></div></div></div></div></section><div class="py-12 md:py-16 px-4 sm:px-6 lg:px-10 bg-gray-50"><div class="max-w-5xl mx-auto text-center mb-8 md:mb-12"><h1 class="text-2xl md:text-3xl lg:text-4xl font-semibold tracking-tight mb-4">Solutions for your Health and Well-Being</h1><p class="text-lg md:text-xl text-center text-gray-600">We provide innovative solutions to improve your health and address well-being challenges.</p></div><div class="max-w-5xl mx-auto grid grid-cols-1 md:grid-cols-2 gap-6 md:gap-12"><div class="bg-white shadow-xl p-6 md:p-8 rounded-3xl transition-shadow h-full flex flex-col"><div class="flex flex-col flex-1 space-y-4"><div class="relative w-full pt-[56.25%] rounded-2xl overflow-hidden"><video class="absolute top-0 left-0 w-full h-full object-cover" autoPlay="" muted="" loop="" playsInl
25ine="" preload="auto"><source src="/videos/osteoporosis_problem.mp4" type="video/mp4"/>Your browser does not support the video tag.</video></div><h2 class="text-xl md:text-2xl font-bold">Osteoporosis</h2><p class="text-gray-600">Osteoporosis weakens bones as breakdown exceeds formation, increasing fracture risk. Bones become thin and porous, often undetected until the first break.</p><div class="flex-1"></div><div class="pt-2"><a href="/en/problem"><button class=" 26 justify-center 27 items-center 28 rounded-full 29 py-3 30 px-6 31 bg-gradient-custom 32 text-white 33 hover:opacity-90 34 transition-opacity 35 36 37 " type="button">Learn more</button></a></div></div></div><div class="bg-white shadow-xl p-6 md:p-8 rounded-3xl transition-shadow h-full flex flex-col"><div class="flex flex-col flex-1 space-y-4"><div class="bg-black relative w-full pt-[56.25%] rounded-2xl overflow-hidden"><img src="/images/short-cote.png" alt="Our Product" class="absolute top-0 left-0 w-full h-full object-contain"/></div><h2 class="text-xl md:text-2xl font-bold">Our Product</h2><p class="text-gray-600">OSTAAT⢠is a non-invasive, connected medical device designed for individuals with osteoporosis, with or without associated severe chronic kidney disease.</p><div class="flex-1"></div><div class="pt-2"><a href="/en/our-product"><button class=" 38 justify-center 39 items-center 40 rounded-full 41 py-3 42 px-6 43 bg-gradient-custom 44 text-white 45 hover:opacity-90 46 transition-opacity 47 48 49 " type="button">Learn more</button></a></div></div></div></div></div><section class="py-12 md:py-20 px-4 sm:px-6 lg:px-8 bg-bgSection"><div class="max-w-7xl mx-auto"><div class="grid gap-8 md:gap-12 lg:grid-cols-[3fr_2fr] lg:items-center"><div class="space-y-6"><h2 class="text-2xl md:text-3xl lg:text-4xl font-semibold tracking-tight">The Origin Behind OSTAATâ¢</h2><p class="text-base sm:text-lg leading-relaxed text-gray-600">After witnessing the devastating impact of osteoporosis-related fractures on his mother and the emotional toll it had on his family, KAT Innovation founder Marcel Maroist recognized the urgent need for a non-invasive, wearable solution capable of supporting bone health while fitting naturally into daily life. 50 51That experience became the foundation for the development of OSTAATâ¢.</p></div><div class="flex justify-center lg:justify-end"><div class="relative w-[65%] max-w-md aspect-square overflow-hidden rounded-lg shadow-xl"><img alt="OstaatOrigin.OstaatOriginImageAlt" decoding="async" data-nimg="fill" class="object-cover" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent" sizes="100vw" srcSet="/_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=640&q=75 640w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=750&q=75 750w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=828&q=75 828w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=1080&q=75 1080w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=1200&q=75 1200w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=1920&q=75 1920w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=2048&q=75 2048w, /_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=3840&q=75 3840w" src="/_next/image?url=%2Fimages%2Fmaman-my_mother.png&w=3840&q=75"/></div></div></div></div></section><div class="py-12 md:py-16 px-4 sm:px-6 lg:px-10 bg-gray-50"><div class="max-w-7xl mx-auto text-center"><h1 class="text-2xl md:text-3xl lg:text-4xl font-semibold tracking-tight mb-8 md:mb-10">Global Statistics</h1><div class="grid grid-cols-1 sm:grid-cols-2 lg:grid-cols-4 gap-4 md:gap-6"><div class="p-4 md:p-6 flex flex-col items-center text-center"><div class="w-16 h-16 md:w-28 md:h-28 flex items-center justify-center mb-2"><video src="/icons/HancheTransparent.webm" autoPlay="" loop="" muted="" class="w-full h-full object-contain rounded-md"></video></div><h1 class="mt-2 md:mt-4 text-xl md:text-2xl font-semibold">8.9M</h1><p class="text-sm md:text-base text-gray-600 text-center">Fractures annually: 1 every 3 seconds.</p></div><div class="p-4 md:p-6 flex flex-col items-center text-center"><div class="w-16 h-16 md:w-28 md:h-28 flex items-center justify-center mb-2"><video src="/icons/FemmeTransparent2.webm" autoPlay="" loop="" muted="" class="w-full h-full object-contain rounded-md"></video></div><h1 class="mt-2 md:mt-4 text-xl md:text-2xl font-semibold">1 / 3</h1><p class="text-sm md:text-base text-gray-600 text-center">Women will suffer a fracture after age 45.</p></div><div class="p-4 md:p-6 flex flex-col items-center text-center"><div class="w-16 h-16 md:w-28 md:h-28 flex items-center justify-center mb-2"><video src="/icons/HommeTransparent2.webm" autoPlay="" loop="" muted="" class="w-full h-full object-contain rounded-md"></video></div><h1 class="mt-2 md:mt-4 text-xl md:text-2xl font-semibold">1 / 5</h1><p class="text-sm md:text-base text-gray-600 text-center">Men will suffer a fracture after age 45.</p></div><div class="p-4 md:p-6 flex flex-col items-center text-center"><div class="w-16 h-16 md:w-28 md:h-28 flex items-center justify-center mb-2"><img alt="Statistic icon" loading="lazy" width="50" height="50" decoding="async" data-nimg="1" class="w-20 h-20 md:w-24 md:h-24 object-contain rounded-md" style="color:transparent" srcSet="/_next/image?url=%2Ficons%2Fearth-resize.png&w=64&q=75 1x, /_next/image?url=%2Ficons%2Fearth-resize.png&w=128&q=75 2x" src="/_next/image?url=%2Ficons%2Fearth-resize.png&w=128&q=75"/></div><h1 class="mt-2 md:mt-4 text-xl md:text-2xl font-semibold">0.5-1%</h1><p class="text-sm md:text-base text-gray-600 text-center">Average annual bone loss on Earth.</p></div><div class="p-4 md:p-6 flex flex-col items-center text-center"><div class="w-16 h-16 md:w-28 md:h-28 flex items-center justify-center mb-2"><img alt="Statistic icon" loading="lazy" width="50" height="50" decoding="async" data-nimg="1" class="w-20 h-20 md:w-24 md:h-24 object-contain rounded-md" style="color:transparent" srcSet="/_next/image?url=%2Ficons%2Fastro-resize.png&w=64&q=75 1x, /_next/image?url=%2Ficons%2Fastro-resize.png&w=128&q=75 2x" src="/_next/image?url=%2Ficons%2Fastro-resize.png&w=128&q=75"/></div><h1 class="mt-2 md:mt-4 text-xl md:text-2xl font-semibold">1-2%</h1><p class="text-sm md:text-base text-gray-600 text-center">Average monthly bone loss in space.</p></div><div class="p-4 md:p-6 flex flex-col items-center text-center"><div class="w-16 h-16 md:w-28 md:h-28 flex items-center justify-center mb-2"><img alt="Statistic icon" loading="lazy" width="50" height="50" decoding="async" data-nimg="1" class="w-20 h-20 md:w-24 md:h-24 object-contain rounded-md" style="color:transparent" srcSet="/_next/image?url=%2Ficons%2FmoneyIcon.png&w=64&q=75 1x, /_next/image?url=%2Ficons%2FmoneyIcon.png&w=128&q=75 2x" src="/_next/image?url=%2Ficons%2FmoneyIcon.png&w=128&q=75"/></div><h1 class="mt-2 md:mt-4 text-xl md:text-2xl font-semibold">$500B</h1><p class="text-sm md:text-base text-gray-600 text-center">21,000 USD per patient annually in the U.S.</p></div><div class="p-4 md:p-6 flex flex-col items-center text-center"><div class="w-16 h-16 md:w-28 md:h-28 flex items-center justify-center mb-2"><img alt="Statistic icon" loading="lazy" width="50" height="50" decoding="async" data-nimg="1" class="w-20 h-20 md:w-24 md:h-24 object-contain rounded-md" style="color:transparent" srcSet="/_next/image?url=%2Ficons%2Fearth-resize.png&w=64&q=75 1x, /_next/image?url=%2Ficons%2Fearth-resize.png&w=128&q=75 2x" src="/_next/image?url=%2Ficons%2Fearth-resize.png&w=128&q=75"/></div><h1 class="mt-2 md:mt-4 text-xl md:text-2xl font-semibold">850 million</h1><p class="text-sm md:text-base text-gray-600 text-center">People worldwide suffer from secondary osteoporosis linked to chronic kidney disease.</p></div><div class="p-4 md:p-6 flex flex-col items-center text-center"><div class="w-16 h-16 md:w-28 md:h-28 flex items-center justify-center mb-2"><img alt="Statistic icon" loading="lazy" width="50" height="50" decoding="async" data-nimg="1" class="w-20 h-20 md:w-24 md:h-24 object-contain rounded-md" style="color:transparent" srcSet="/_next/image?url=%2Ficons%2Fangel.png&w=64&q=75 1x, /_next/image?url=%2Ficons%2Fangel.png&w=128&q=75 2x" src="/_next/image?url=%2Ficons%2Fangel.png&w=128&q=75"/></div><h1 class="mt-2 md:mt-4 text-xl md:text-2xl font-semibold">1 in 4</h1><p class="text-sm md:text-base text-gray-600 text-center">Hip fracture patients die within a year after surgery; without surgery, this rises to 3 in 4.</p></div></div></div></div><div class="py-12 md:py-16 px-4 sm:px-6 lg:px-20 bg-bgSection"><div class="max-w-7xl mx-auto grid gap-8 lg:grid-cols-3 lg:items-center"><div class="space-y-6 lg:col-span-2"><h1 class="text-2xl md:text-3xl lg:text-4xl font-semibold tracking-tight">Our Team</h1><p class="text-base md:text-lg leading-relaxed text-gray-600">Our multidisciplinary team brings together experts from various backgrounds, including electrical and biomedical engineers, kinesiologists, physiologists, and biologists, all under the enlightened leadership of our CEO-Founder and supported by our scientific advisors. This strategic combination of skills ensures a strong position on the path to success.</p><div class="pt-2"><a href="/en/about-us#our-team"><button class=" 52 justify-center 53 items-center 54 rounded-full 55 py-3 56 px-6 57 bg-gradient-custom 58 text-white 59 hover:opacity-90 60 transition-opacity 61 62 63 " type="button">Learn more</button></a></div></div><div class="max-w-2xl mx-auto lg:mx-0"><div class="space-y-6"><div class="grid grid-cols-2 gap-4"><div class="aspect-square overflow-hidden rounded-xl shadow-md"><img alt="CEO of KAT Innovation" loading="lazy" width="200" height="200" decoding="async" data-nimg="1" class="object-cover" style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fteam%2Fceo.png&w=256&q=75 1x, /_next/image?url=%2Fimages%2Fteam%2Fceo.png&w=640&q=75 2x" src="/_next/image?url=%2Fimages%2Fteam%2Fceo.png&w=640&q=75"/></div><div class="aspect-square overflow-hidden rounded-xl shadow-md"><img alt="Caroline, team member" loading="lazy" width="200" height="200" decoding="async" data-nimg="1" class="object-cover" style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fteam%2Fcaroline.png&w=256&q=75 1x, /_next/image?url=%2Fimages%2Fteam%2Fcaroline.png&w=640&q=75 2x" src="/_next/image?url=%2Fimages%2Fteam%2Fcaroline.png&w=640&q=75"/></div><div class="aspect-square overflow-hidden rounded-xl shadow-md"><img alt="Team.silvermanAlt" loading="lazy" width="200" height="200" decoding="async" data-nimg="1" class="object-cover" style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fteam%2FDr_Stuart_Silverman.jpg&w=256&q=75 1x, /_next/image?url=%2Fimages%2Fteam%2FDr_Stuart_Silverman.jpg&w=640&q=75 2x" src="/_next/image?url=%2Fimages%2Fteam%2FDr_Stuart_Silverman.jpg&w=640&q=75"/></div><div class="aspect-square overflow-hidden rounded-xl shadow-md"><img alt="Ramzi, team member" loading="lazy" width="200" height="200" decoding="async" data-nimg="1" class="object-cover" style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fteam%2F5.png&w=256&q=75 1x, /_next/image?url=%2Fimages%2Fteam%2F5.png&w=640&q=75 2x" src="/_next/image?url=%2Fimages%2Fteam%2F5.png&w=640&q=75"/></div></div></div></div></div></div><section id="contact-us" class="py-12 md:py-20 px-4 sm:px-6 lg:px-8 bg-gray-50"><div class="max-w-4xl mx-auto"><div class="text-center mb-8 md:mb-12"><h2 class="text-2xl md:text-3xl lg:text-4xl font-semibold tracking-tight">Contact us</h2><div class="text-gray-600 mt-2 md:mt-4 text-base md:text-lg "><p class="text-center ">We're here to answer your questions and collaborate on groundbreaking solutions.</p><p class="text-center ">Reach out to us today!</p></div></div><div class="bg-white rounded-xl shadow-lg p-6 md:p-8"><form class="space-y-6"><div><label for="name" class="block text-sm font-medium text-gray-700">Full name<span class="text-red-600"> *</span></label><input type="text" id="name" placeholder="Write your full name" class="mt-1 block w-full px-4 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-blue-500" required="" name="name"/></div><div><label for="email" class="block text-sm font-medium text-gray-700">Email<span class="text-red-600"> *</span></label><input type="email" id="email" placeholder="[email protected]" class="mt-1 block w-full px-4 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-blue-500" required="" name="email"/></div><div><label for="subject" class="block text-sm font-medium text-gray-700">Subject<span class="text-red-600"> *</span></label><input type="text" id="subject" placeholder="Subject" class="mt-1 block w-full px-4 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-blue-500" required="" name="subject"/></div><div><label for="message" class="block text-sm font-medium text-gray-700">Message<span class="text-red-600"> *</span></label><textarea id="message" name="message" rows="5" placeholder="Enter your question or message..." class="mt-1 block w-full px-4 py-2 border border-gray-300 rounded-lg focus:ring-2 focus:ring-blue-500 focus:border-blue-500" required=""></textarea></div><div class="flex justify-center w-full"><button class=" 64 justify-center 65 items-center 66 rounded-full 67 py-3 68 px-6 69 bg-gradient-custom 70 text-white 71 hover:opacity-90 72 transition-opacity 73 74 75 " type="submit">Send Message</button></div></form>
75<section class="Toastify" aria-live="polite" aria-atomic="false" aria-relevant="additions text" aria-label="Notifications Alt+T"></section></div></div></section></div><footer class="bg-bgSection"><div class="mx-auto px-20 py-6"><div class="lg:flex lg:items-start lg:gap-8"><div><a href="/en"><img alt="KAT Innovation Logo" width="130" height="130" decoding="async" data-nimg="1" style="color:transparent" srcSet="/_next/image?url=%2Flogo-kat.png&w=256&q=75 1x, /_next/image?url=%2Flogo-kat.png&w=384&q=75 2x" src="/_next/image?url=%2Flogo-kat.png&w=384&q=75"/></a></div><div class="mt-8 grid grid-cols-2 gap-8 lg:mt-0 lg:grid-cols-5 lg:gap-y-16"><div class="col-span-2"><h2 class="text-2xl font-bold text-dark">Get the latest news!</h2><p class="text-grey">Subscribe to our newsletter to stay up to date</p></div><div class="col-span-2 lg:col-span-3 flex items-center justify-center"><form class="w-full max-w-lg"><label for="UserEmail" class="sr-only">Email</label><div class="border bg-white rounded-full border-gray-200 px-2 focus-within:ring flex items-center sm:flex-row"><input type="email" id="UserEmail" placeholder="[email protected]" class="w-full border-none rounded-full text-sm p-4 focus:outline-none focus:ring-0 focus:border-transparent" required=""/><button class="hidden sm:block bg-gradient-to-r from-[#33629B] via-[#099F70] to-[#B7CE05] rounded-full px-6 py-3 text-sm font-bold uppercase tracking-wide text-white">Subscribe</button></div><div class="mt-3 sm:hidden flex justify-center"><button class="w-full bg-gradient-to-r from-[#33629B] via-[#099F70] to-[#B7CE05] rounded-full px-6 py-3 text-sm font-bold uppercase tracking-wide text-white">Subscribe</button></div></form></div><div class="col-span-2 sm:col-span-1"><p class="font-medium text-gray-900">About us</p><ul class="mt-4 space-y-2 text-sm"><li><a class="text-gray-700 transition hover:opacity-75" href="/en/about-us">The Company</a></li><li><a class="text-gray-700 transition hover:opacity-75" href="/en/about-us#mission">Our Mission</a></li><li><a class="text-gray-700 transition hover:opacity-75" href="/en/about-us#our-founder">Our Founder</a></li><li><a class="text-gray-700 transition hover:opacity-75" href="/en/about-us#our-team">Our Team</a></li><li><a class="text-gray-700 transition hover:opacity-75" href="/en/about-us#partners">Our Partners</a></li></ul></div><div class="col-span-2 sm:col-span-1"><p class="font-medium text-gray-900">Problem & Solution</p><ul class="mt-4 space-y-2 text-sm"><li><a class="text-gray-700 transition hover:opacity-75" href="/en/problem">The problem</a></li><li><a class="text-gray-700 transition hover:opacity-75" href="/en/solution">The solution</a></li></ul></div><div class="col-span-2 sm:col-span-1"><p class="font-medium text-gray-900">Our Products</p><ul class="mt-4 space-y-2 text-sm"><li><a class="text-gray-700 transition hover:opacity-75" href="/en/our-product#ostaat">OSTAATâ¢</a></li><li><a class="text-gray-700 transition hover:opacity-75" href="/en/our-product#space">Space Osteoporosis</a></li><li><a class="text-gray-700 transition hover:opacity-75" href="/en/our-product#healthcare">Healthcare for All</a></li></ul></div><div class="col-span-2 sm:col-span-1"><p class="font-medium text-gray-900">News</p><ul class="mt-4 space-y-2 text-sm"><li><a class="text-gray-700 transition hover:opacity-75" href="/en/news">News & Announcements</a></li></ul></div></div></div><div class="mt-8 border-t border-gray-400 pt-8"><div class="grid grid-cols-1 sm:grid-cols-2 gap-2 items-center"><p class="text-xs text-grey text-center sm:text-left">Copyright ©2022 KAT Innovation Inc. - All rights reserved. OSTAAT⢠is a trademark of KAT Innovation Inc.</p><ul class="flex flex-wrap justify-center sm:justify-end items-center gap-4 text-xs"><li><a class="text-grey hover:text-blue-500 transition-colors" href="mailto:[email protected]">[email protected]</a></li><li class="h-6 w-6 flex items-center justify-center shrink-0"><a target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/katInnovation2020"><img alt="Facebook" loading="lazy" width="30" height="30" decoding="async" data-nimg="1" class="hover:scale-110 transition-transform" style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fsocialnet%2Ffb.png&w=32&q=75 1x, /_next/image?url=%2Fimages%2Fsocialnet%2Ffb.png&w=64&q=75 2x" src="/_next/image?url=%2Fimages%2Fsocialnet%2Ffb.png&w=64&q=75"/></a></li><li class="h-6 w-6 flex items-center justify-center shrink-0"><a target="_blank" rel="noopener noreferrer" href="https://www.linkedin.com/company/kat-innovation/posts/?feedView=all"><img alt="LinkedIn" loading="lazy" width="30" height="30" decoding="async" data-nimg="1" class="hover:scale-110 transition-transform" style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fsocialnet%2Flinked.png&w=32&q=75 1x, /_next/image?url=%2Fimages%2Fsocialnet%2Flinked.png&w=64&q=75 2x" src="/_next/image?url=%2Fimages%2Fsocialnet%2Flinked.png&w=64&q=75"/></a></li><li class="h-6 w-6 flex items-center justify-center shrink-0"><a target="_blank" rel="noopener noreferrer" href="https://www.f6s.com/company/kat-innovation-inc"><img alt="F6S" loading="lazy" width="30" height="30" decoding="async" data-nimg="1" class="hover:scale-110 transition-transform" style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fsocialnet%2Ffs.png&w=32&q=75 1x, /_next/image?url=%2Fimages%2Fsocialnet%2Ffs.png&w=64&q=75 2x" src="/_next/image?url=%2Fimages%2Fsocialnet%2Ffs.png&w=64&q=75"/></a></li><li class="h-6 w-6 flex items-center justify-center shrink-0"><a target="_blank" rel="noopener noreferrer" href="https://gust.com/companies/kat-innovation"><img alt="Gust" loading="lazy" width="30" height="30" decoding="async" data-nimg="1" class="hover:scale-110 transition-transform" style="color:transparent" srcSet="/_next/image?url=%2Fimages%2Fsocialnet%2Fgust2.png&w=32&q=75 1x, /_next/image?url=%2Fimages%2Fsocialnet%2Fgust2.png&w=64&q=75 2x" src="/_next/image?url=%2Fimages%2Fsocialnet%2Fgust2.png&w=64&q=75"/></a></li></ul></div></div></div></footer>
75<script src="/_next/static/chunks/webpack-0bfbc16c93757d76.js" async=""></script>
75<script>(self.__next_f=self.__next_f||[]).push([0])</script>
75<script>self.__next_f.push([1,"1:\"$Sreact.fragment\"\n2:I[5244,[],\"\"]\n3:I[3866,[],\"\"]\n5:I[3910,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"87\",\"static/chunks/87-7e5cd4c266b609b6.js\",\"465\",\"static/chunks/app/%5Blocale%5D/page-d1e19f60fdc30825.js\"],\"default\"]\n6:I[1547,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"87\",\"static/chunks/87-7e5cd4c266b609b6.js\",\"465\",\"static/chunks/app/%5Blocale%5D/page-d1e19f60fdc30825.js\"],\"default\"]\n7:I[7878,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"87\",\"static/chunks/87-7e5cd4c266b609b6.js\",\"465\",\"static/chunks/app/%5Blocale%5D/page-d1e19f60fdc30825.js\"],\"default\"]\n8:I[9030,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"87\",\"static/chunks/87-7e5cd4c266b609b6.js\",\"465\",\"static/chunks/app/%5Blocale%5D/page-d1e19f60fdc30825.js\"],\"default\"]\n9:I[5170,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"87\",\"static/chunks/87-7e5cd4c266b609b6.js\",\"465\",\"static/chunks/app/%5Blocale%5D/page-d1e19f60fdc30825.js\"],\"default\"]\na:I[2240,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"87\",\"static/chunks/87-7e5cd4c266b609b6.js\",\"465\",\"static/chunks/app/%5Blocale%5D/page-d1e19f60fdc30825.js\"],\"default\"]\nb:I[2982,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"87\",\"static/chunks/87-7e5cd4c266b609b6.js\",\"465\",\"static/chunks/app/%5Blocale%5D/page-d1e19f60fdc30825.js\"],\"default\"]\nc:I[6213,[],\"OutletBoundary\"]\ne:I[6213,[],\"MetadataBoundary\"]\n10:I[6213,[],\"ViewportBoundary\"]\n12:I[4835,[],\"\"]\n14:I[26"])</script>
75<script>self.__next_f.push([1,"87,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"450\",\"static/chunks/app/%5Blocale%5D/layout-c8a0e19d9e635596.js\"],\"default\"]\n19:I[5897,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"450\",\"static/chunks/app/%5Blocale%5D/layout-c8a0e19d9e635596.js\"],\"default\"]\n1a:I[8016,[\"540\",\"static/chunks/540-97d91d4b11344914.js\",\"877\",\"static/chunks/877-ee309be1ac8e8911.js\",\"173\",\"static/chunks/173-f571c60da90961a5.js\",\"450\",\"static/chunks/app/%5Blocale%5D/layout-c8a0e19d9e635596.js\"],\"default\"]\n:HL[\"/_next/static/css/606d1024b658d130.css\",\"style\"]\n:HL[\"/_next/static/css/d440bf5f48d6ae05.css\",\"style\"]\n:HL[\"/_next/static/css/e7eddfe4828c1690.css\",\"style\"]\n"])</script>
75<script>self.__next_f.push([1,"0:{\"P\":null,\"b\":\"owHSksrthXxQ6WHD10Bpo\",\"p\":\"\",\"c\":[\"\",\"en\"],\"i\":false,\"f\":[[[\"\",{\"children\":[[\"locale\",\"en\",\"d\"],{\"children\":[\"__PAGE__\",{}]},\"$undefined\",\"$undefined\",true]}],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L2\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L3\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[],[[\"$\",\"title\",null,{\"children\":\"404: This page could not be found.\"}],[\"$\",\"div\",null,{\"style\":{\"fontFamily\":\"system-ui,\\\"Segoe UI\\\",Roboto,Helvetica,Arial,sans-serif,\\\"Apple Color Emoji\\\",\\\"Segoe UI Emoji\\\"\",\"height\":\"100vh\",\"textAlign\":\"center\",\"display\":\"flex\",\"flexDirection\":\"column\",\"alignItems\":\"center\",\"justifyContent\":\"center\"},\"children\":[\"$\",\"div\",null,{\"children\":[[\"$\",\"style\",null,{\"dangerouslySetInnerHTML\":{\"__html\":\"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}\"}}],[\"$\",\"h1\",null,{\"className\":\"next-error-h1\",\"style\":{\"display\":\"inline-block\",\"margin\":\"0 20px 0 0\",\"padding\":\"0 23px 0 0\",\"fontSize\":24,\"fontWeight\":500,\"verticalAlign\":\"top\",\"lineHeight\":\"49px\"},\"children\":404}],[\"$\",\"div\",null,{\"style\":{\"display\":\"inline-block\"},\"children\":[\"$\",\"h2\",null,{\"style\":{\"fontSize\":14,\"fontWeight\":400,\"lineHeight\":\"49px\",\"margin\":0},\"children\":\"This page could not be found.\"}]}]]}]}]]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"locale\",\"en\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/606d1024b658d130.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"$undefined\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/d440bf5f48d6ae05.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"$undefined\"}]],\"$L4\"]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[[\"$\",\"div\",null,{\"className\":\"text-dark\",\"children\":[[\"$\",\"$L5\",null,{}],[\"$\",\"$L6\",null,{}],[\"$\",\"$L7\",null,{}],[\"$\",\"$L8\",null,{}],[\"$\",\"$L9\",null,{}],[\"$\",\"$La\",null,{}],[\"$\",\"$Lb\",null,{}]]}],[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/e7eddfe4828c1690.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"$undefined\"}]],[\"$\",\"$Lc\",null,{\"children\":\"$Ld\"}]]}],{},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[\"$\",\"$1\",\"aofluVjroR7W4t5egoYol\",{\"children\":[[\"$\",\"$Le\",null,{\"children\":\"$Lf\"}],[\"$\",\"$L10\",null,{\"children\":\"$L11\"}],null]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",\"$undefined\"],\"s\":false,\"S\":false}\n"])</script>
75<script>self.__next_f.push([1,"4:[\"$\",\"html\",null,{\"lang\":\"en\",\"children\":[\"$\",\"body\",null,{\"children\":\"$L13\"}]}]\n15:T50c,Osteoporosis is a serious disease affecting more than 2 million people in Canada and 200 million worldwide. The disease costs the healthcare system over $2.3 billion in Canada and nearly $500 billion worldwide. A silent disease, osteoporosis is more common than stroke, heart attack, breast cancer, and cancer combined.\n\nOsteoporosis primarily affects postmenopausal women, with one in three experiencing an osteoporotic fracture after age 50. However, men are also at risk, with one in four men over 55 suffering fractures. The consequences are severeâ20-30% of individuals with hip fractures die within a year. As the population ages, fracture risks are projected to double in the next 20 years.\n\nOsteoporosis is characterized by decreased bone mineral density, making bones brittle and prone to fractures. The most common fractures occur in the wrist, hip, and spine, significantly impacting quality of life. Factors such as genetics, lack of exercise, smoking, alcoholism, poor diet, and certain medications contribute to the condition.\n\nAddressing osteoporosis is crucial due to its widespread impact and the high mortality risks associated with fractures. Strategies must focus on prevention, early diagnosis, and effective treatment to reduce the burden of this debilitating disease.16:T587,In the absence of Earth's gravitational force, bones are no longer subjected to their usual mechanical stresses. This lack of mechanical stimulation leads to bone deterioration, as the body no longer perceives the need to maintain significant bone mass. This loss of bone density can result in structural fragility and significantly increase the risk of fractures when astronauts return to Earth's gravitational environment.\n\nThe rate of bone density loss in space (1-2% per month) far exceeds that of post-menopausal women and older men on Earth (0.5-1% per year). Weight-bearing exercises, crucial for bone health, are challenging to replicate in a weight"])</script>
75<script>self.__next_f.push([1,"less environment.\n\nTo mitigate bone loss, astronauts follow specialized exercise and nutrition programs before, during, and after space missions. These programs focus on preserving bone mass, stimulating growth, and promoting regeneration. Adequate calcium and vitamin D3 intake are essential.\n\nUpon return to Earth, astronauts undergo personalized rehabilitation programs developed by medical professionals in collaboration with space agencies. These programs aim to strengthen both bones and muscles.\n\nKAT Innovation's potential involvement in this field could contribute to ongoing research for maintaining astronauts' bone health. Our exploration of an innovative, chemical-free, non-invasive technology to stimulate bone growth offers numerous benefits:17:T544,We have already developed our mobile application â a technological cornerstone of our solution.\n\nDesigned to serve both clinical research needs and the experience of end users, the app plays a central role in our data collection and analysis strategy.\n\nFor clinical studies, it enables real-time collection of precise data on device usage, participant adherence, subjective feedback, and clinical indicators. All data collected in this context is strictly anonymized and treated as confidential, in compliance with applicable ethical and regulatory standards.\n\nFor users, the app provides an intuitive interface to track their sessions, receive personalized reminders, monitor progress, and access educational content. All personal data is fully secured and remains strictly confidential, in accordance with international data protection standards (e.g., GDPR, HIPAA).\n\nBeyond its operational function, the app is a true driver of data-driven innovation: the securely collected data will feed into our predictive treatment response model. This AI-based model will eventually allow us to adapt and personalize stimulation protocols based on individual profiles, optimizing clinical outcomes.\n\nOur app is more than a tracking tool â it is at the heart of a connected, preventive, "])</script>
75<script>self.__next_f.push([1,"personalized healthcare approach that fully respects user privacy.18:T489,On a global scale, access to healthcare remains a major challenge for many populations, particularly those living in remote or disadvantaged areas. This problem is not limited to Canada but affects communities worldwide. For example, according to the World Health Organization, about half of the world's population lacks access to essential health services.\n\nOur medical device, in the form of smart clothing, would represent a major advancement in the options available to treat osteoporosis and prevent the risk of fractures, not only for remote populations but also for those facing other obstacles in accessing care.\n\nThanks to the integration of cutting-edge technologies in the electrode areas of the clothing, we will be able to measure body composition and impedance in real-time. The integrated artificial intelligence will allow for real-time personalization of treatment, thus offering optimal monitoring and support to people with limited access to healthcare, whether they live in remote areas or face other barriers. Moreover, our 5G technology will enable a direct link with patients living in remote regions or without easy access to healthcare."])</script>
75<script>self.__next_f.push([1,"13:[\"$\",\"$L14\",null,{\"formats\":\"$undefined\",\"locale\":\"en\",\"messages\":{\"Navbar\":{\"aboutUs\":\"About us\",\"problem\":\"Problem\",\"solution\":\"Solution\",\"ourProduct\":\"Our Product\",\"frax\":\"FRAX\",\"achievements\":\"Achievements\",\"news\":\"News\",\"clinicalvalidations\":\"Clinical Validations\",\"home\":\"Home\",\"en\":\"EN\",\"fr\":\"FR\"},\"MainSection\":{\"heading\":\"Transforming Bone Health Through Precision Bioelectronicsâ¢\",\"description\":\"KAT Innovation is developing a first-in-class Precision Bone Bioelectronics⢠Platform, a scalable ecosystem of wearable bioelectronic therapies for skeletal health, from Earth to Space Health.\",\"learnMore\":\"Learn more\",\"videoFallback\":\"Your browser does not support the video tag.\",\"logoAlt\":\"Partner Logo\"},\"AboutUs\":{\"heading\":\"About us\",\"description\":\"KAT Innovation develops and commercializes cutting-edge Precision Bone Bioelectronics⢠Platform technologies to address unmet needs in skeletal health, from Earth to Space Health. Founded on a genuine passion for innovation, KAT Innovation is dedicated to designing technologies that can change lives. Marcel Maroist, CEO and founder, is a dynamic and committed entrepreneur with extensive experience in health, fitness, and sports. His vision drives the company's mission: to establish the Precision Bone Bioelectronics⢠Platform as the global reference in bone health innovation.\",\"learnMore\":\"Learn more\",\"ceoImageAlt\":\"Marcel Maroist, CEO of KAT Innovation\"},\"SolutionPage\":{\"title\":\"Solution - KAT Innovation\",\"description\":\"Discover our innovative health solutions for well-being.\"},\"Solution\":{\"heading\":\"Solutions for your Health and Well-Being\",\"description\":\"We provide innovative solutions to improve your health and address well-being challenges.\",\"osteoporosis\":{\"title\":\"Osteoporosis\",\"description\":\"Osteoporosis weakens bones as breakdown exceeds formation, increasing fracture risk. Bones become thin and porous, often undetected until the first break.\"},\"ourProduct\":{\"title\":\"Our Product\",\"description\":\"OSTAAT⢠is a non-invasive, connected medical device designed for individuals with osteoporosis, with or without associated severe chronic kidney disease.\"},\"learnMore\":\"Learn more\",\"videoFallback\":\"Your browser does not support the video tag.\"},\"OstaatOrigin\":{\"heading\":\"The Origin Behind OSTAATâ¢\",\"description\":\"After witnessing the devastating impact of osteoporosis-related fractures on his mother and the emotional toll it had on his family, KAT Innovation founder Marcel Maroist recognized the urgent need for a non-invasive, wearable solution capable of supporting bone health while fitting naturally into daily life.\\n\\nThat experience became the foundation for the development of OSTAATâ¢.\",\"ceoImageAlt\":\"Marcel Maroist, CEO of KAT Innovation\"},\"StatisticsPage\":{\"title\":\"Statistics - KAT Innovation\",\"description\":\"Explore global statistics on bone health and osteoporosis.\"},\"Statistics\":{\"heading\":\"Global Statistics\",\"iconAlt\":\"Statistic icon\",\"stats\":{\"fractures\":{\"value\":\"8.9M\",\"description\":\"Fractures annually: 1 every 3 seconds.\"},\"womenFracture\":{\"value\":\"1 / 3\",\"description\":\"Women will suffer a fracture after age 45.\"},\"menFracture\":{\"value\":\"1 / 5\",\"description\":\"Men will suffer a fracture after age 45.\"},\"boneLossEarth\":{\"value\":\"0.5-1%\",\"description\":\"Average annual bone loss on Earth.\"},\"boneLossSpace\":{\"value\":\"1-2%\",\"description\":\"Average monthly bone loss in space.\"},\"costUS\":{\"value\":\"$$500B\",\"description\":\"21,000 USD per patient annually in the U.S.\"},\"secondaryOsteoporosis\":{\"value\":\"850 million\",\"description\":\"People worldwide suffer from secondary osteoporosis linked to chronic kidney disease.\"},\"hipFractureMortality\":{\"value\":\"1 in 4\",\"description\":\"Hip fracture patients die within a year after surgery; without surgery, this rises to 3 in 4.\"}}},\"Team\":{\"heading\":\"Our Team\",\"description\":\"Our multidisciplinary team brings together experts from various backgrounds, including electrical and biomedical engineers, kinesiologists, physiologists, and biologists, all under the enlightened leadership of our CEO-Founder and supported by our scientific advisors. This strategic combination of skills ensures a strong position on the path to success.\",\"learnMore\":\"Learn more\",\"learnMoreAria\":\"Learn more about our team\",\"ceoAlt\":\"CEO of KAT Innovation\",\"carolineAlt\":\"Caroline, team member\",\"stephaneAlt\":\"Stephane, team member\",\"ramziAlt\":\"Ramzi, team member\",\"stuartAlt\":\"Stuart, team member\"},\"ContactUs\":{\"heading\":\"Contact us\",\"descriptionPart1\":\"We're here to answer your questions and collaborate on groundbreaking solutions.\",\"descriptionPart2\":\"Reach out to us today!\",\"form\":{\"name\":{\"label\":\"Full name\",\"placeholder\":\"Write your full name\"},\"email\":{\"label\":\"Email\",\"placeholder\":\"[email protected]\"},\"subject\":{\"label\":\"Subject\",\"placeholder\":\"Subject\"}
75,\"message\":{\"label\":\"Message\",\"placeholder\":\"Enter your question or message...\"},\"submit\":\"Send Message\"},\"toastSuccess\":\"ð Email sent successfully! We will get back to you as soon as possible.\",\"toastError\":\"â Failed to send email. Please try again later.\"},\"Footer\":{\"logoAlt\":\"KAT Innovation Logo\",\"newsletter\":{\"title\":\"Get the latest news!\",\"description\":\"Subscribe to our newsletter to stay up to date\",\"form\":{\"emailLabel\":\"Email\",\"emailPlaceholder\":\"[email protected]\",\"subscribe\":\"Subscribe\"}},\"sections\":{\"aboutUs\":{\"title\":\"About us\",\"links\":{\"company\":\"The Company\",\"mission\":\"Our Mission\",\"founder\":\"Our Founder\",\"team\":\"Our Team\",\"partners\":\"Our Partners\"}},\"problemSolution\":{\"title\":\"Problem \u0026 Solution\",\"links\":{\"problem\":\"The problem\",\"solution\":\"The solution\"}},\"products\":{\"title\":\"Our Products\",\"links\":{\"ostaat\":\"OSTAATâ¢\",\"space\":\"Space Osteoporosis\",\"healthcare\":\"Healthcare for All\"}},\"news\":{\"title\":\"News\",\"links\":{\"announcements\":\"News \u0026 Announcements\"}}},\"copyright\":\"Copyright ©2022 KAT Innovation Inc. - All rights reserved. OSTAAT⢠is a trademark of KAT Innovation Inc.\",\"contactEmail\":\"[email protected]\",\"social\":{\"facebookAlt\":\"Facebook\",\"linkedinAlt\":\"LinkedIn\",\"f6sAlt\":\"F6S\",\"gustAlt\":\"Gust\"}},\"Company\":{\"company\":{\"title\":\"The Company\",\"descriptionPart1\":\"KAT Innovation is developing a first-in-class Precision Bone Bioelectronics⢠Platform, a scalable technology ecosystem designed to support multiple products, therapeutic indications, and future generations of wearable bioelectronic therapies for skeletal health. The Platform integrates proprietary bioelectronic stimulation technologies, wearable medical electronics, smart textile systems, computational modelling, clinical science, connected digital health capabilities, and intellectual property within a common technological foundation.\",\"descriptionPart2\":\"Founded on a genuine passion for innovation and a deeply personal motivation, KAT Innovation is dedicated to designing and realizing technologies that can change lives. Marcel Maroist, CEO and founder, is a dynamic and committed entrepreneur with extensive experience in health, fitness, and sports, whose own family's experience with osteoporosis first revealed the need for a better solution. His expertise has enabled him to assemble a multidisciplinary team of seasoned professionals, and KAT Innovation aspires to lead the medical and healthcare technology industry with advanced solutions that enhance health outcomes and streamline the work of medical professionals.\",\"descriptionPart3\":\"The Platform's first intended commercial application, OSTAAT⢠(One Stimulation At A Time), is being developed as a smart wearable medical device initially targeting women aged 50 and over who are newly diagnosed with osteoporosis. The lead application is focused on the hip, one of the most clinically significant anatomical sites for fragility fractures, disability, loss of independence, and healthcare expenditure.\",\"descriptionPart4\":\"To design a connected, effective, and state-of-the-art platform, KAT Innovation prioritizes international collaboration. Since its inception, the company has expanded globally, establishing KAT Innovation Canada (Montreal), KAT Innovation France (Paris), KAT Innovation Technologies Spain (Malaga), KAT Innovation USA (Chicago / Beverly Hills), and soon KAT Innovation UK Ltd.\"},\"mission\":{\"title\":\"Our Mission \u0026 Our Vision\",\"descriptionPart1\":\"At KAT Innovation, our mission is to develop clinically validated \u003cbold\u003ePrecision Bone Bioelectronicsâ¢\u003c/bold\u003e technologies that improve bone health, reduce fracture risk and empower people to live fully, preserving their mobility, independence and quality of life.\",\"descriptionPart2\":\"KAT Innovation aspires to be the world's defining force in \u003cbold\u003ePrecision Bone Bioelectronicsâ¢\u003c/bold\u003e, redefining how the world prevents and manages bone fragility through clinically validated, non-invasive therapies.\",\"imageAlt\":\"Mission illustration\"}},\"OurFounder\":{\"title\":\"Our Founder\",\"hero\":{\"description\":\"Marcel Maroist, CEO, and founder of KAT Innovation, brings over four decades of extensive experience in corporate management and event organization across diverse sectors. His career began with ownership of a paramedical clinic in Quebec City, followed by management of a sports medicine center in Montreal's North Shore. Passionate about physical activity and health, Marcel has practiced martial arts since age 12, achieving the prestigious rank of 8th-degree black belt Taekwondo Grandmaster and establishing more than fifteen Taekwondo schools globally.\",\"
75imageAlt\":\"Marcel Maroist, CEO and Founder\"},\"secondary\":{\"descriptionPart1\":\"With a background in physical education and a profound commitment to sports and health, Marcel devoted over 13 years to health research, leading and funding the development of medical devices and overseeing clinical trials. His expertise spans from research and development to the commercialization of innovative healthcare solutions.\",\"descriptionPart2\":\"Since 2011, Marcel has integrated his medical research expertise with martial arts principles of resilience, perseverance, and tenacity. Alongside his professional endeavors, he maintains a fervent enthusiasm for sports and health.\",\"descriptionPart3\":\"Today, he leads KAT Innovation with a strong commitment to innovation in healthcare and achieving excellence in management, exerting influence across North America, Europe, Australia and Asia.\",\"imageAlt\":\"Our Founder illustration\"}},\"OurTeam\":{\"title\":\"Our Team\",\"descriptionPart1\":\"Our multidisciplinary team brings together experts from various backgrounds, including electrical and biomedical engineers, kinesiologists, physiologists, and biologists, all under the enlightened leadership of our CEO-Founder and supported by our scientific advisors. This strategic combination of skills ensures a strong position on the path to success.\",\"descriptionPart2\":\"For nearly 4 years, we have had the privilege of collaborating with distinguished scientific advisors, including physicians, both in Quebec and abroad.\",\"descriptionPart3\":\"The list of physicians and hospitals eager to participate in our project is impressive: rheumatologists, orthopedists, geriatricians, and nephrologists from prestigious institutions such as the University of Montreal Health Centre (CHUM), CHU of Bordeaux, Limoges, and Poitiers in France, University Hospitals of Malaga and Granada in Spain, Mongi Slim Hospital in Tunis, and the Osteoporosis Medical Center in Los Angeles (UCLA Health-Cedars Sinai Hospital).\",\"descriptionPart4\":\"These experts play a crucial role in guiding and advising us, significantly contributing to all phases of our studies, from pilot studies to preclinical animal studies, including a multicenter study involving this extensive international team of physicians.\",\"loading\":\"Loading team members...\",\"error\":\"Error: {message}\",\"errors\":{\"fetchFailed\":\"Failed to fetch team members.\",\"unknown\":\"An unknown error occurred\"},\"memberAlt\":\"Profile picture of {name}\",\"roles\":{\"marcel-maroist\":\"CEO Founder\",\"caroline-chevrier\":\"B.A., C. Mkt, EMBA, SBA â Strategic Business Advisor | North American Market\",\"stephane-lepine\":\"LL.B., MBA, CLSO - Chief Legal Strategy Officer\",\"eric-szmutny\":\"Vice President, Quality, Innovation, and Regulatory Affairs\",\"keklevi-ansah\":\"EPM, Engineering Project Manager\",\"dr-ramzi-bouzidi\":\"Professor of Orthopaedic Surgery - Scientific Advisor\",\"dr-stuart-silverman\":\"MD, F.A.C.P., F.A.C.R. Rheumatologist - Principal Investigator\",\"alain-steve-comptois\":\"Inventor - Scientific Advisor\",\"jean-boucher\":\"Inventor - Scientific Advisor\",\"james-andrew-hodgdon\":\"Inventor - Scientific Advisor\",\"roland-savard\":\"Scientific Advisor\",\"sammie-heard\":\"Biomedical Engineering Researcher\",\"nick-dernovsek\":\"Biomedical Engineering Researcher\",\"shubham-patel\":\"Software Developer \u0026 Project Lead\",\"francois-de-montigny\":\"IT Specialist\",\"brigitte-marcheterre\":\"B.Sc, DESS, CCOO â Chief Clinical Operation Officer\"}},\"TeamMember\":{\"loading\":\"Loading...\",\"notFound\":\"Team member not found!\",\"imageAlt\":\"Profile picture of {name}\",\"connect\":\"Connect\",\"linkedin\":\"LinkedIn Profile\",\"researchgate\":\"ResearchGate Profile\",\"about\":\"About\"},\"SustainableDevelopment\":{\"title\":\"Sustainable Development\",\"description\":\"Sustainability is a fundamental principle ingrained across OSTAATâ¢'s design and operations. We aim to deliver world-class osteoporosis therapy while minimizing environmental impact through the following initiatives:\",\"initiatives\":{\"materialConservation\":{\"title\":\"Material Conservation\",\"description\":\"Our conductive polymer electrodes improve energy efficie
75ncy and reduce battery usage by 20% compared to competitors.\"},\"recyclableProducts\":{\"title\":\"Recyclable Products\",\"description\":\"In the next 5 years, we aim to have over 85% recyclability in our medical garments and hardware using bioplastics.\"},\"responsibleManufacturing\":{\"title\":\"Responsible Manufacturing\",\"description\":\"We partner with suppliers adhering to top sustainability standards, including renewable energy, ethical labor, and wastewater treatment, with a focus on ISO 14001 certification.\"},\"streamlinedLogistics\":{\"title\":\"Streamlined Logistics\",\"description\":\"By centralizing fulfillment and optimizing kitting for our products, we have reduced shipping emissions by a margin of over 30%.\"}},\"sdgSectionTitle\":\"Aligning with SDGs\",\"sdgImageAlt\":\"SDG {id} icon\",\"sdgs\":{\"sdg3\":{\"title\":\"SDG 3\",\"description\":\"Good Health and Wellbeing: OSTAAT⢠transforms bone health for osteoporosis patients globally, enhancing patient outcomes through rigorous monitoring and continuous improvement.\"},\"sdg5\":{\"title\":\"SDG 5\",\"description\":\"Gender Equality: By addressing the high incidence of osteoporosis in women, OSTAAT⢠empowers women to manage their bone health, promoting mobility, independence, and participation in social and economic activities.\"},\"sdg8\":{\"title\":\"SDG 8\",\"description\":\"Decent Work and Economic Growth: Our growth fosters job creation and sustainable economic development, supporting equitable employment opportunities.\"},\"sdg9\":{\"title\":\"SDG 9\",\"description\":\"Industry, Innovation, and Infrastructure: Through continuous innovation and inclusive partnerships, OSTAAT⢠advances patient-centric osteoporosis care, shaping the future of health technologies.\"}}},\"Partners\":{\"loading\":\"Loading partners...\",\"error\":\"Error: {message}\",\"noPartners\":\"No partners found.\",\"title\":\"Our Partners \u0026 Collaborators\",\"description\":\"We would like to extend our warmest thanks to our partners, who contribute to the success of our company. Thank you for your involvement, dedication and invaluable collaboration. We look forward to working with you for many years to come!\"},\"OsteoporosisSection\":{\"title\":\"What is Osteoporosis?\",\"videoFallback\":\"Your browser does not support the video tag.\",\"videoDescription\":\"Osteoporosis is a disease in which osteoclasts are much more active than osteoblasts, making bones more fragile and more likely to fracture. People affected have thinner bones and a more porous spongy layer. It is a silent disease that gradually reduces the density and quality of bones, weakening them over the years. In most cases, the disease goes undetected because no symptoms are identified until the first fracture occurs.\",\"mainDescription\":\"Osteoporosis is a very serious disease; it is more common than stroke, heart attacks, and breast cancer combined. Osteoporosis is often related to age and decreases in ovarian activity, leading to a drop in estrogen levels. Other factors, such as certain cancers and prescribed medications, can also contribute. Tragically, some people afflicted with hip fractures caused by osteoporosis succumb within a year of the fracture.\\n\\nThe seriousness of this problem is underlined by hip fracture statistics. A quarter of those who undergo surgery for a hip fracture face mortality within twelve months. Three out of four who choose not to undergo surgery face an equally grim fate within the same timeframe.\",\"expandableDescription\":\"$15\"},\"KidneyDiseaseSection\":{\"title\":\"Osteoporosis \u0026 Chronic Kidney Disease\",\"mainDescription\":\"The situation is even worse for people with osteoporosis related to severe chronic kidney disease. In these cases, the mortality rate from hip fractures is alarming (as high as 70%), underscoring the need for rapid intervention and concrete solutions.\\n\\nOsteoporosis and chronic kidney disease (CKD) are two distinct medical conditions, but there is a close relationship between them. People with CKD are at increased risk of osteoporosis.\\n\\nChronic kidney disease can affect bone health in several ways, which can lead to the development of osteoporosis in patients with CKD.\",\"
75imageAlt\":\"Illustration of kidneys\",\"expandableIntro\":\"Here are some of the factors that contribute to this association:\",\"expandableFactor1\":\"\u003cstrong\u003eHormone imbalance:\u003c/strong\u003e CKD disrupts hormone levels, including PTH, which regulates calcium.\",\"expandableFactor2\":\"\u003cstrong\u003eCalcium and phosphate deregulation:\u003c/strong\u003e Impaired kidney function affects bone mineralization.\",\"expandableFactor3\":\"\u003cstrong\u003eMetabolic acidosis:\u003c/strong\u003e CKD prevents acid elimination, increasing bone loss.\",\"expandableFactor4\":\"\u003cstrong\u003eMedications:\u003c/strong\u003e Certain CKD treatments negatively impact bone health.\",\"expandableMeasuresIntro\":\"Preventive measures for osteoporosis in CKD patients:\",\"preventiveMeasures\":[\"Calcium- and vitamin D-rich diet.\",\"Regular weight-bearing exercises.\",\"Careful selection of medications.\",\"Bone density monitoring.\",\"Proper CKD management.\"],\"expandableConclusion\":\"OSTAAT⢠low-intensity electrical stimulation technology provides a non-invasive solution for bone health, especially for CKD patients who cannot take conventional osteoporosis drugs.\"},\"MedicationSection\":{\"title\":\"Medication \u0026 Side Effects\",\"mainDescription\":\"Osteoporosis treatment presents significant challenges, particularly for patients with severe chronic kidney disease (CKD). Due to impaired renal function, traditional medications are contraindicated for this group, leaving them with few or no viable options. Even for those with primary osteoporosis, available medications often come with a high risk of side effects and complex administration protocols.\\n\\nThe disease itself carries serious implications beyond bone fragility. Osteoporotic fractures can lead to life-threatening complications such as infections and blood clots. Moreover, the condition may cause spinal deformities, potentially compressing internal organs and further compromising overall health.\\n\\nCurrent osteoporosis medications are notoriously difficult to administer correctly. Patients must take them on an empty stomach, remain upright for a specified period, and carefully time their doses in relation to other medications and meals. These stringent requirements contribute to poor adherence rates.\",\"imageAlt\":\"Illustration of medication side effects\",\"statistics\":[\"25% of diagnosed patients refuse to initiate recommended treatments.\",\"52% of those who start treatment discontinue within 24 months.\",\"Consequently, 64% of the diagnosed population receives no treatment at all.\"],\"expandableDescription\":\"This significant untreated population represents a substantial market opportunity for innovative solutions. Furthermore, the remaining 36% currently on medication might be open to alternative, more manageable treatment options.\"},\"Common\":{\"expandableContent\":{\"expand\":\"Read More\",\"collapse\":\"Dismiss\"}},\"IntroSection\":{\"title\":\"OSTAATâ¢\",\"description1\":\"OSTAAT⢠is a non-invasive connected medical device designed for people affected by osteopenia or osteoporosis, with or without associated severe chronic kidney disease.\",\"imageAlt\":\"Illustration d'OSTAATâ¢\",\"description2\":\"The technology involves applying a low-intensity electric current with no side effects. The current acts on cell membrane mechanisms, allowing calcium to enter the cells, thus promoting bone growth. The technology can be used preventively, to reduce the risk of fractures of all kinds, or curatively, to accelerate the healing process of fractures* caused by osteoporosis, severe chronic kidney disease, or other conditions. At the cutting edge of technology, the OSTAAT⢠device in its prototype belt version for clinical studies and its smart clothing version, will be able to be activated via a mobile app accessible on cell phone, tablet, or computer.\\n\\n*Claims will be addressed in future clinical trials.\"},\"UnmetNeedSection\":{\"title\":\"A Solution to an Urgent, Unmet Need in Bone Health\",\"description1\":\"Every year, millions of women over 50 are newly diagnosed with osteoporosis and immediately face a dangerous treatment gap. While medications exist, they take 6 to 12 months to begin working, and much longer to show meaningful effects at the hip, the most life-threatening fracture site. During this vulnerable period, patients remain at very high risk of fractures, with no effective short-term protection.\\n\\nThis situation is even more alarming when we consider that nearly 40% of patients refuse medication altogether, most often due to fear of side effects, according to a survey conducted in 2016 by the Bone Health \u0026 Osteoporosis Foundation. Among those who start treatment, over 50% will discontinue within one to two years.\\n\\nOSTAAT⢠technology was created to fill this critical and persistent gap, offering immediate, drug-free, non-invasive support for bone health starting at diagnosis.\",\"imageAlt\":\"Illustration of a solution\",\"expandableDescription1title\":\"Bridging the Critical Fracture Risk Gap\",\"expandableDescription1pre\":\"OSTAAT⢠is a wearable device that delivers targeted, low-intensity electrical stimulation to activate natural bone growth, precisely when it matters most. It addresses the urgent need for early intervention in patients who:\",\"expandableDescription1list\":[\"Are waiting for medication to take effect.\",\"Refuse or cannot tolerate drug treatment.\",\"Are likely to discontinue medication.\",\"Or are unable to comply with complex treatments, such as patients with dementia.\"],\"expandableDescription1post\":\"People living with cognitive decline or dementia often face a double burden: they are at high risk of falls and fractures due to impaired mobility and balance and are frequently unable to adhere to medication protocols. OSTAAT⢠provides a safe, easy-to-use alternative that fits seamlessly into daily life â even for those with memory or mobility challenges.\",\"expandableDescription2title\":\"Transforming Care for CKD Patients\",\"expandableDescription2\":\"OSTAAT⢠also meets an urgent need in another overlooked population: the 850+ million people worldwide with chronic kidney disease (CKD), including 135 million with advanced CKD. These patients are at high risk of osteoporosis and fractures but are often excluded from pharmacologic treatment due to medical contraindications.\\n\\n With no safe medication options, CKD patients are left unprotected, facing progressive bone loss, fragile bones, and increased mortality. \\n\\nOSTAAT⢠offers these patients a breakthrough solution, making it possible to proactively manage bone health without drugs.\",\"expandableDescription3title\":\"OSTAATâ¢: A New Standard for Fragility Fracture Prevention\",\"expandableDescription3pre\":\"Whether it's:\",\"expandableDescription3list\":[\"Women newly diagnosed with osteoporosis.\",\"Patients who refuse or discontinue medication.\",\"People with dementia who cannot manage complex therapies.\",\"Or individuals with CKD, for whom drugs are contraindicated.\"],\"expandableDescription3post\":\"OSTAAT⢠fills a dangerous gap left wide open by conventional treatment. \\n\\nIt's not just an innovation. It's a lifesaving bridge to stronger bonesâ¦when patients need it most.\"}
75,\"ScientificEvidenceSection\":{\"title\":\"Scientific Evidence\",\"description1\":\"The OSTAAT⢠device uses a sophisticated low-intensity electrical current to stimulate bone growth. This innovative and patented technology, the result of rigorous academic research, has undergone extensive studies to elucidate its mechanism of action on osteogenesis.\",\"descriptionFootnote\":\"*Patents pending.\",\"expandableIntro\":\"The scientific validation of OSTAAT⢠is based on a comprehensive research program:\",\"studies\":[\"In vitro studies: Examination of the direct effects of electrical stimulation on bone cells.\",\"Ex vivo preclinical trials: Validation of the efficacy of optimized electrical parameters on bone samples under controlled conditions.\",\"Clinical investigations: Evaluation of the device's efficacy and safety in human subjects.\"],\"study1\":\"\u003cstrong\u003eIn vitro studies:\u003c/strong\u003e Examination of the direct effects of electrical stimulation on bone cells.\",\"study2\":\"\u003cstrong\u003eEx vivo preclinical trials:\u003c/strong\u003e Validation of the efficacy of optimized electrical parameters on bone samples under controlled conditions.\",\"study3\":\"\u003cstrong\u003eClinical investigations:\u003c/strong\u003e Evaluation of the device's efficacy and safety in human subjects.\",\"expandableDescription\":\"These multidimensional studies have demonstrated OSTAATâ¢'s potential as a non-pharmacological alternative for osteoporosis and bone disorders related to chronic kidney disease, particularly for patients intolerant to traditional drug treatments.\\n\\nThe discovery of a link between electrical stimulation and bone growth led to an exhaustive review of scientific literature, generating new hypotheses currently being studied in collaboration with university researchers.\\n\\nAn in vitro study, conducted in partnership with UQAM since August 2022, has confirmed the initial hypothesis on the link between electrical stimulation and bone formation. The results validate the device's voltage parameters, essential for stimulating ion channels responsible for calcium deposition in cells.\\n\\nThese advances will soon be presented at scientific conferences and published in international journals, marking a crucial step towards launching a multicenter clinical study.\"},\"UniqueSolutionSection\":{\"title\":\"The Uniqueness of Our Solution\",\"description\":\"OSTAAT⢠technology represents a groundbreaking advancement in the treatment of osteopenia and osteoporosis with or without severe chronic kidney disease, offering a unique and innovative approach to bone health management.\",\"imageAlt\":\"Illustration of unique solution\",\"feature1\":\"\u003cstrong\u003eNon-invasive and side-effect free:\u003c/strong\u003e Unlike many pharmacological treatments that can cause adverse effects, OSTAAT⢠stimulates bone growth without any known side effects.\",\"features\":[\"\u003cstrong\u003eNon-invasive and side-effect free:\u003c/strong\u003e Unlike many pharmacological treatments that can cause adverse effects, OSTAAT⢠stimulates bone growth without any known side effects.\",\"\u003cstrong\u003eHome-based, portable treatment:\u003c/strong\u003e OSTAAT⢠allows patients to self-administer treatment in the comfort of their own homes, improving accessibility and treatment adherence.\",\"\u003cstrong\u003ePersonalized therapy:\u003c/strong\u003e The intuitive controller enables patients to customize treatment intensity, tailoring the therapy to their individual needs and comfort levels.\",\"\u003cstrong\u003eInternal stimulation of osteoblasts:\u003c/strong\u003e OSTAATâ¢'s unique approach directly stimulates osteoblasts through low-intensity electrical current, promoting bone growth from within.\",\"\u003cstrong\u003eSmart clothing integration:\u003c/strong\u003e OSTAAT⢠technology can be incorporated into smart clothing, allowing patients to receive treatment while going about their daily routines.\",\"\u003cstrong\u003eArtificial intelligence and 5G connectivity:\u003c/strong\u003e The device utilizes AI to create personalized treatment prediction models and leverages 5G technology for real-time reactions.\",\"\u003cstrong\u003eUser-friendly mobile app:\u003c/strong\u003e OSTAAT⢠can be controlled via a mobile app accessible on smartphones, tablets, or computers.\"],\"feature2\":\"\u003cstrong\u003eHome-based, portable treatment:\u003c/strong\u003e OSTAAT⢠allows patients to self-administer treatment in the comfort of their own homes, improving accessibility and treatment adherence.\",\"feature3\":\"\u003cstrong\u003ePersonalized therapy:\u003c/strong\u003e The intuitive controller enables patients to customize treatment intensity, tailoring the therapy to their individual needs and comfort levels.\",\"feature4\":\"\u003cstrong\u003eInternal stimulation of osteoblasts:\u003c/strong\u003e OSTAATâ¢'s unique approach directly stimulates osteoblasts through low-intensity electrical current, promoting bone growth from within.\",\"feature5\":\"\u003cstrong\u003eSmart clothing integration:\u003c/strong\u003e OSTAAT⢠technology can be incorporated into smart clothing, allowing patients to receive treatment while going about their daily routines.\",\"feature6\":\"\u003cstrong\u003eArtificial intelligence and 5G connectivity:\u003c/strong\u003e The device utilizes AI to create personalized treatment prediction models and leverages 5G technology for real-time reactions.\",\"feature7\":\"\u003cstrong\u003eUser-friendly mobile app:\u003c/strong\u003e OSTAAT⢠can be controlled via a mobile app accessible on smartphones, tablets, or computers.\",\"expandableConclusion\":\"By combining cutting-edge technology with a deep understanding of bone physiology, OSTAAT⢠offers a safe, effective, and convenient alternative to traditional osteoporosis treatments.\"},\"ClinicalPathwaySection\":{\"title\":\"Clinical Pathway\",\"mainDescription\":\"O
75STAAT⢠technology shows promise in stimulating osteoblasts, counteracting osteoclast impact, and influencing H-type blood vessels crucial for bone homeostasis. This systematic approach aims to thoroughly validate this non-invasive bone growth technology, potentially offering a new treatment option for various bone-related conditions.\\n\\nOur innovative approach to bone growth stimulation raised numerous questions regarding the effects of electrical stimulation on bone growth mechanisms. To address these, our scientific team conducted a comprehensive review of existing literature, identifying key areas for investigation.\\n\\nFollowing this analysis, we initiated in vitro and ex vivo trials to elucidate and demonstrate the mechanisms of action of our OSTAAT⢠technology. These preliminary investigations were designed to pave the way for future pilot and multicenter clinical trials, ultimately enabling us to validate the efficacy and safety of our device in human subjects.\",\"imageAlt\":\"Scientists in a laboratory\",\"expandableIntro\":\"Our trials focused on testing hypotheses formulated by our scientific team regarding the relationships between OSTAAT⢠electrical stimulation and various bone-related processes:\",\"hypotheses\":[\"Cell membrane action mechanisms.\",\"Calcium entry into cells.\",\"Differentiation between osteoblasts and osteoclasts.\",\"Bone formation and resorption processes.\",\"Voltage-gated ion channels.\",\"The role of parathyroid hormone (PTH).\",\"Blood calcium regulation.\",\"Type H blood vessels and endothelial cells.\"],\"expandableResults\":\"Our scientists' hypotheses yielded promising results, suggesting that electrical stimulation OSTAAT⢠at specific voltages influences cell membrane mechanisms, promoting calcium entry into bone cells and stimulating bone growth in a manner mimicking natural calcium influx pathways. These findings, currently confidential, will be the subject of forthcoming scientific publications.\",\"expandableTrials\":\"The in vitro trials also addressed additional hypotheses, with results to be included in upcoming publications. This proof of concept has propelled us towards the next crucial phase: pilot and multicenter clinical trials involving patients with osteopenia, osteoporosis, or chronic kidney disease-related osteoporosis.\",\"expandableBoneMass\":\"Preliminary results indicate a significant increase in bone mass using OSTAATâ¢, driving us towards more extensive clinical trials in collaboration with renowned institutions. Concurrently, we are exploring potential applications of our technology to support bone health in astronauts during extended space missions, offering a possible solution to bone density loss in microgravity environments.\",\"expandableDevelopment\":\"\u003cstrong\u003eClinical Development of OSTAATâ¢\u003c/strong\u003e The clinical development of OSTAAT⢠has followed a systematic approach, progressing from preliminary studies to planned human trials.\",\"expandableCurrentFocus\":\"\u003cstrong\u003eCurrent Focus: In Vitro and Ex Vivo Trials\u003c/strong\u003e\",\"currentTrials\":[\"In vitro trials began in August 2022 at UQAM, collaborating with Professor Tatiana Scorza and master's student Arleth Pozo Delugo.\",\"These trials investigate mechanisms of action related to cell membranes, calcium entry, osteoblast/osteoclast differences, bone formation/resorption, voltage-gated ion channels, PTH hormone, blood calcium regulation, and type H blood vessels.\",\"Initial results demonstrate that OSTAAT⢠electrical stimulation at specific voltages promotes calcium entry into bone cells, stimulating growth.\",\"An ex vivo preclinical trial on animal tissue, conducted at the Polytechnique de Montréal in June 2024, validated certain electrical parameters of OSTAAT⢠technology.\"],\"expandableNextSteps\":\"\u003cstrong\u003eNext Steps: Clinical Studies\u003c/strong\u003e\",\"clinicalTrials\":[\"Pilot trials on osteoporosis patients:\",\"Multicenter clinical trial on patients with osteopenia, osteoporosis, and osteoporosis related to chronic kidney disease:\"],\"clinicalTr
75ial1\":\"\u003cstrong\u003ePilot trials on osteoporosis patients:\u003c/strong\u003e\",\"clinicalTrial1Institutions\":[\"Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada: Principal investigator: Dr. Julio Fernandes, MD, PhD, MBA, FRCSC, orthopedic surgeon.\",\"Osteoporosis Medical Center, UCLA Health, Cedars Sinai Hospital, Los Angeles, USA: Co-investigator: Dr. Stuart L. Silverman, MD, F.A.C.P., F.A.C.R., Rheumatologist.\"],\"clinicalTrial2\":\"\u003cstrong\u003eMulticenter clinical trial on patients with osteopenia, osteoporosis, and osteoporosis related to chronic kidney disease:\u003c/strong\u003e\",\"clinicalTrial2Institutions\":[\"Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada: Principal investigator: Dr. Julio Fernandes, MD, PhD, MBA, FRCSC, orthopedic surgeon.\",\"Osteoporosis Medical Center, UCLA Health, Cedars Sinai Hospital, Los Angeles, USA: Co-investigator: Dr. Stuart L. Silverman, MD, F.A.C.P., F.A.C.R., Rheumatologist.\",\"Mongi Slim Hospital, Tunis, Tunisia: Dr. Ramzi Bouzidi, Chief Medical Officer of KAT Innovation, Orthopedic surgeon.\",\"Pellegrin Hospital, Bordeaux University Hospital, Bordeaux, France: Dr. Thierry Schaeverbeke, M.D., Rheumatologist.\",\"Chu Dupuytren Limoges EMIS Platform, Limoges, France: Florence Bosselut.\",\"Regional University Hospital of Malaga, Spain: Dr. Francisco Luna Cabrera and Dr. Ana Belen Paba.\",\"University of Granada Hospital, Granada, Spain: Dr. Rafael Caliz Caliz.\",\"Potential partners in England with NIHR/NHS.\"],\"expandableFutureProjects\":\"\u003cstrong\u003eFuture Projects\u003c/strong\u003e\",\"futureProjects\":[\"In vivo trials are planned for the next two years (2024-2026) to confirm the results and explore new avenues.\",\"Conducting multicenter clinical trials in collaboration with internationally renowned medical institutions.\",\"Evaluating OSTAATâ¢'s role in accelerating fracture healing.\",\"Investigating its application in astronaut bone health.\",\"Exploring new therapeutic avenues.\"],\"expandableValidation\":\"These studies will validate our OSTAAT⢠technology under various clinical conditions and explore its potential in cutting-edge fields such as space medicine.\",\"expandableNote\":\"\u003cstrong\u003eNote:\u003c/strong\u003e Submission of scientific articles for publication is scheduled for the first quarter of 2025. Detailed technical reports (\\\"White Papers\\\") are available upon request from our research team.\"},\"OSTAATSection\":{\"title\":\"OSTAATâ¢: Our Official Product\",\"description\":\"OSTAAT⢠is a groundbreaking smart clothing solution that integrates state-of-the-art bone growth stimulation technology into comfortable, wearable garments. Our innovative product combines non-invasive medical treatment with everyday comfort, allowing users to receive therapy while engaging in their daily activities. Unlike pulse electromagnetic fields and ultrasound, which are typically used for non-union fractures, OSTAAT⢠is designed specifically for the treatment of osteoporosis and to prevent and reduce the risk of fractures. OSTAAT⢠is also distinct from electrical muscle stimulators or TENS, further emphasizing its unique focus on bone health and fracture prevention. Unlike implantable stimulators that require surgery, OSTAAT⢠offers a non-invasive alternative for improving bone health in a convenient and comfortable way.\",\"imageAlt1\":\"OSTAAT smart clothing product 1\",\"imageAlt2\":\"OSTAAT smart clothing product 2\",\"imageAlt3\":\"OSTAAT smart clothing product 3\",\"imageAlt4\":\"OSTAAT smart clothing product 4\",\"keyFeatures\":\"\u003cstrong\u003eKey Features:\u003c/strong\u003e\",\"features\":[\"Integrated technology: OSTAAT⢠features conductive polymer electrodes seamlessly embedded in compressive clothing, controlled by a compact electrical device with a long-lasting rechargeable battery.\",\"Targeted treatment: Designed to stimulate bone growth in specific areas like the hips and spine.\",\"Comfort and ergonomics: Our design ensures a comfortable fit, using soft, breathable materials suitable for physical activity and everyday wear.\",\"Versatility and ease of use: Available in multiple sizes to accommodate various body types, OSTAAT⢠is designed for easy donning and doffing. The magnetic connection for the device ensures simple and secure attachment.\",\"Breathability: The fabric used in OSTAAT⢠allows excellent air circulation, wicking away moisture and maintaining a comfortable temperature during wear.\",\"Hypoallergenic properties: OSTAAT⢠is made from naturally hypoallergenic raw materials and uses hypoallergenic dyes, minimizing the risk of skin irritation or allergic reactions.\",\"User-friendly control: OSTAAT⢠can be easily controlled via an app on smartphones, tablets, or computers, allowing intuitive function management.\",\"AI-powered optimization: We harness artificial intelligence to develop a cutting-edge model that predicts optimal treatment strategies for individual patients.\",\"Environmental consciousness: All components of OSTAAT⢠are recyclable, reflecting our commitment to sustainability.\",\"Durability and care:
75Smart garments are reusable, easy to clean (hand-washable), and designed for long-term sessions lasting a minimum of 5 years. The electrodes are mounted on a thin, stretchable substrate that can withstand multiple washings.\",\"Safety and comfort: Our product is free from vibrations and muscle contractions, with no side effects, offering both preventive and curative* care. (*A statement that will be addressed in future clinical trials).\"],\"feature1\":\"\u003cstrong\u003eIntegrated technology:\u003c/strong\u003e OSTAAT⢠features conductive polymer electrodes seamlessly embedded in compressive clothing, controlled by a compact electrical device with a long-lasting rechargeable battery.\",\"feature2\":\"\u003cstrong\u003eTargeted treatment:\u003c/strong\u003e Designed to stimulate bone growth in specific areas like the hips and spine.\",\"feature3\":\"\u003cstrong\u003eComfort and ergonomics:\u003c/strong\u003e Our design ensures a comfortable fit, using soft, breathable materials suitable for physical activity and everyday wear.\",\"feature4\":\"\u003cstrong\u003eVersatility and ease of use:\u003c/strong\u003e Available in multiple sizes to accommodate various body types, OSTAAT⢠is designed for easy donning and doffing. The magnetic connection for the device ensures simple and secure attachment.\",\"feature5\":\"\u003cstrong\u003eBreathability:\u003c/strong\u003e The fabric used in OSTAAT⢠allows excellent air circulation, wicking away moisture and maintaining a comfortable temperature during wear.\",\"feature6\":\"\u003cstrong\u003eHypoallergenic properties:\u003c/strong\u003e OSTAAT⢠is made from naturally hypoallergenic raw materials and uses hypoallergenic dyes, minimizing the risk of skin irritation or allergic reactions.\",\"feature7\":\"\u003cstrong\u003eUser-friendly control:\u003c/strong\u003e OSTAAT⢠can be easily controlled via an app on smartphones, tablets, or computers, allowing intuitive function management.\",\"feature8\":\"\u003cstrong\u003eAI-powered optimization:\u003c/strong\u003e We harness artificial intelligence to develop a cutting-edge model that predicts optimal treatment strategies for individual patients.\",\"feature9\":\"\u003cstrong\u003eEnvironmental consciousness:\u003c/strong\u003e All components of OSTAAT⢠are recyclable, reflecting our commitment to sustainability.\",\"feature10\":\"\u003cstrong\u003eDurability and care:\u003c/strong\u003e Smart garments are reusable, easy to clean (hand-washable), and designed for long-term sessions lasting a minimum of 5 years. The electrodes are mounted on a thin, stretchable substrate that can withstand multiple washings.\",\"feature11\":\"\u003cstrong\u003eSafety and comfort:\u003c/strong\u003e Our product is free from vibrations and muscle contractions, with no side effects, offering both preventive and curative* care. (*A statement that will be addressed in future clinical trials).\",\"expandableDescription\":\"OSTAAT⢠is particularly beneficial for individuals with osteoporosis and chronic kidney disease. By combining advanced technology with user-friendly design, OSTAAT⢠represents the future of wearable medical devices, providing effective treatment of osteoporosis without compromising on comfort or style.\\n\\nOur commitment to quality extends to every aspect of OSTAATâ¢, from its professional appearance to its robust, reliable performance. Fabric selection ensures optimal biocompatibility, comfort, and signal transmission capacity, while maintaining durability and ease of maintenance.\\n\\nWith OSTAATâ¢, we're revolutionizing bone growth stimulation, making it more accessible, comfortable, and integrated into daily life than ever before. Our smart clothing combines innovation, comfort, and effectiveness to provide a superior solution for bone health management.\"},\"SpaceSection\":{\"title\":\"Astronauts \u0026 Bone Loss\",\"mainDescription\":\"Revolutionizing bone regeneration research, OSTAAT⢠addresses the critical issue of bone loss in astronauts during space missions. Our cutting-edge solutions aim to stimulate bone growth and combat spaceflight-induced osteopenia.\\n\\nIn microgravity, astronauts can lose 1-2% of their bone mass monthly, primarily affecting legs, hips, and spine. This loss stems from multiple factors: absence of gravity, lack of resistance exercise, metabolic and hormonal changes, radiation exposure, and nutritional challenges. OSTAAT⢠offers innovative solutions to counter these effects, complementing existing exercise programs and tailored diets for astronauts.\\n\\nBone loss, particularly decreased bone density, is a major obstacle for extended space missions, including those to Mars. In zero-gravity environments, astronauts' bones degrade ten times faster than osteoporosis patients on Earth, posing serious health risks upon return.\",\"imageAlt\":\"Illustration of astronaut bone health\",\"expandableDescription\":\"$16\",\"benefits\":[\"Prevention or reduction of bone density loss in weightlessness.\",\"Promotion of bone growth and strengthening.\",\"Facilitation of faster recovery upon return to Earth.\",\"Mitigation of fracture risks and other bone-related health complications.\"],\"expandableConclusion\":\"This technology's applications extend beyond space missions. Findings from space studies could lead to treatments for bone diseases and fractures on Earth, benef
75iting bedridden patients and individuals with mobility limitations.\\n\\nIn conclusion, addressing bone loss in astronauts not only ensures their long-term health but also advances science for the benefit of the general population, echoing the challenges of osteoporosis and contributing to improved musculoskeletal health for all.\"},\"MobileAppSection\":{\"title\":\"KAT Innovation - Mobile App\",\"mainDescription\":\"$17\",\"imageAlt\":\"Mobile app screenshot\"},\"HealthcareSection\":{\"title\":\"Access to Healthcare for All\",\"mainDescription\":\"$18\",\"imageAlt\":\"Illustration of healthcare access\",\"expandableDescription\":\"This technology could significantly reduce complications related to hip fractures, which are often fatal in remote communities due to the lack of rapid access to specialized surgical care.\\n\\nUltimately, our innovative technology offers a promising solution to significantly improve bone health and, by extension, the quality of life of underserved populations around the world. Whether in remote areas, disadvantaged urban regions, or any other place where access to healthcare is limited, our device has the potential to bridge existing gaps in the management of osteoporosis and other bone disorders, thus paving the way for better health equity on a global scale.\"},\"CertificationsPage\":{\"heading\":\"White papers and published scientific publications related to our technology are available upon request.\\n\\nTo contact us, please fill our contact form.\",\"contactButton\":\"Contact Us\"},\"ClinicalValidationPage\":{\"heading\":\"KAT Innovation is working with healthcare professionals to clinically evaluate and validate its technologies. The Letters of Intent below demonstrate the interest of clinical partners in supporting future validation studies and helping ensure our solutions meet the needs of patients and healthcare providers.\",\"contactButton\":\"Contact Us\"},\"NewsList\":{\"loading\":\"Loading articles...\"},\"Pagination\":{\"ariaLabel\":\"Page navigation example\",\"first\":\"First\",\"previous\":\"Previous\",\"next\":\"Next\",\"last\":\"Last\"},\"ArticleDetail\":{\"loading\":\"Loading...\",\"error\":\"Article not found!\"},\"Commonn\":{\"readMore\":\"Read More\",\"dismiss\":\"Dismiss\"},\"AchievementsSection\":{\"title\":\"Achievements \u0026 Recognition\",\"description\":\"KAT Innovation has demonstrated outstanding early-stage traction through global recognition, successful funding, and clinical progress. Since inception, we've raised over CAD $1 million in non-dilutive grants for R\u0026D, prototyping, and clinical validation. In 2024, we were chosen as one of only 8 startups (from 250) for the prestigious mHUB MedTech Accelerator in Chicago, gaining USD $250,000 equity funding and mentorship. We also secured a spot in the MassChallenge U.S. Early Stage Cohort, selected as 128 from 1,300+ applicants.\",\"awards\":{\"title\":\"International Recognition and Awards (2020â2025)\",\"description\":\"Since 2020, KAT Innovation has earned 18 international awards and distinctions, including:\",\"list\":{\"1\":{\"award\":\"Favorite Startup\",\"recognizer\":\"Centech Montréal cohort\",\"date\":\"Fall 2020\",\"link\":\"https://www.katinnovation.com/en/news/27\"},\"2\":{\"award\":\"Innovation Prize Winner\",\"recognizer\":\"CreaVienne, France\",\"date\":\"March 2021\",\"link\":\"https://www.katinnovation.com/en/news/26\"},\"3\":{\"award\":\"Best Startup Canada\",\"recognizer\":\"Recognition by BestStartup.ca\",\"date\":\"May 2021\",\"link\":\"https://www.katinnovation.com/en/news/177\"},\"4\":{\"award\":\"Top 10 Finalist\",\"recognizer\":\"Startup of the Year, Montreal NewTech Gala\",\"date\":\"December 2021\",\"link\":\"https://www.katinnovation.com/en/news/21\"},\"5\":{\"award\":\"Elevator Pitch Winner\",\"recognizer\":\"Grande Messe de Startup Montréal, MTL Connecte\",\"date\":\"May 2022\",\"link\":\"https://www.katinnovation.com/en/news/10\"},\"6\":{\"award\":\"Top 25 Winner\",\"recognizer\":\"C2 Montréal Emerging Entrepreneurs\",\"date\":\"June 2022\",\"link\":\"https://www.katinnovation.com/en/news/11\"},\"7\":{\"award\":\"Top 6 Finalist\",\"recognizer\":\"Taiwan Mobileheroes Connectivity Innovation Challenge\",\"date\":\"November 2022\",\"link\":\"https://www.katinnovation.com/en/news/12\"},\"8\":{\"award\":\"Top 4 Finalist\",\"recognizer\":\"ADRIQ Innovation Awards Gala\",\"date\":\"November 2022\",\"link\":\"https://www.katinnovation.com/en/news/15\"},\"9\":{\"award\":\"Selected\",\"recognizer\":\"Boston IMPACT M2D2 Accelerator (only Canadian company)\",\"date\":\"February 2023\",\"link\":\"https://www.katinnovation.com/en/news/9\"},\"10\":{\"award\":\"CEO featured in high-profile podcast interview\",\"recognizer\":\"Startup Canada\",\"date\":\"April 2023\",\"link\":\"https://www.katinnovation.com/en/news/17\"},\"11\":{\"award\":\"Participant\",\"recognizer\":\"FemTech Paris Accelerator Program\",\"date\":\"September 2023 â March 2024\",\"link\":\"https://www.katinnovation.com/en/news/4\"},\"12\":{\"award\":\"KAT Innovation recognized in the UK\",\"recognizer\":\"Via FemTech Lab London\",\"date\":\"Q1 2024\",\"link\":\"https://www.katinnovation.com/en/news/2\"},\"13\":{\"award\":\"Golden Cheetah Award Winner\",\"recognizer\":\"FemTech Lab, London\",\"date\":\"February 2024\",\"link\":\"https://www.katinnovation.com/en/news/2\"},\"14\":{\"award\":\"Silver Award Winner\",\"recognizer\":\"AcexHealth Accelerator, Spain\",\"date\":\"March 2024\",\"link\":\"https://www.katinnovation.com/en/news/7\"},\"15\":{\"award\":\"Top 6 Finalist\",\"recognizer\":\"Health Orbit Call by the Canadian Space Agency \u0026 Medteq+\",\"date\":\"March 2024\"},\"16\":{\"award\":\"3rd Place Winner\",\"recognizer\":\"\\\"Win the Future\\\" Global Entrepreneur Competition, Suzhou, China\",\"date\":\"May 2024\"},\"17\":{\"award\":\"Selected\",\"recognizer\":\"MassChallenge U.S. Early-Stage Cohort\",\"date\":\"May 2024\"},\"18\":{\"award\":\"Participant\",\"recognizer\":\"mHUB Chicago MedTech Program\",\"date\":\"November 2024 â May 2025\",\"link\":\"https://www.katinnovation.com/en/news/28\"}}},\"conclusion\":\"These achievements demonstrate our consistent global traction, innovation leadership, and growing confidence from evaluators, investors, and strategic partners across North America, Europe, and Asia.\"},\"clinicalvalidations\":{\"title\":\"Clinical Validations\",\"description\":\"KAT Innovation is working with healthcare professionals to clinically evaluate and validate its technologies. The Letters of Intent below demonstrate the interest of clinical partners in supporting future validation studies and helping ensure our solutions meet the needs of patients and healthcare providers.\",\"loading\":\"Loading letters...\",\"error\":\"Error: {message}\",\"errors\":{\"fetchFailed\":\"Failed to load letters of support\",\"unknown\":\"Something went wrong\"},\"names\":{\"dr-zalazar\":\"Dr. Zalazar\",\"dr-gold\":\"Dr. Gold\",\"dr-fowe\":\"Dr. Fowe\",\"dr-bouzidi\":\"Dr. Bouzidi\",\"dr-silverman\":\"Dr. Silverman\"}}}
75,\"now\":\"$undefined\",\"timeZone\":\"UTC\",\"children\":[[\"$\",\"$L19\",null,{}],[\"$\",\"$L2\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\",\"$0:f:0:1:2:children:0\",\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L3\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1a\",null,{}]]}]\n"])</script>
75<script>self.__next_f.push([1,"11:[[\"$\",\"meta\",\"0\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1\"}]]\nf:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"title\",\"1\",{\"children\":\"KAT innovation\"}],[\"$\",\"meta\",\"2\",{\"name\":\"description\",\"content\":\"Welcome to · KAT Innovation · A Future Free From Osteoporotic Fractures · Solution: Bone Growth Stimulation · Our Product: OSTAAT â¢. One STimulation At A Time.\"}],[\"$\",\"link\",\"3\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"link\",\"4\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\"}]]\nd:null\n"])</script>
75</body></html>
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.